LymphedemaV1, Main, Exploration, bibRecord, 002883

Lymphedema following taxane-based chemotherapy in women with early breast cancer.

Identifieur interne : 002883 ( Main/Exploration ); précédent : 002882; suivant : 002884

Lymphedema following taxane-based chemotherapy in women with early breast cancer.

Auteurs : Mi-Joung Lee [Australie] ; Jane Beith ; Leigh Ward ; Sharon Kilbreath

Source :

Lymphatic research and biology [ 1557-8585 ] ; 2014.

RBID : pubmed:25411764

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Australie (épidémiologie), Bras (anatomopathologie), Cyclophosphamide (administration et posologie), Douleur (), Douleur (épidémiologie), Doxorubicine (administration et posologie), Femelle, Fluorouracil (administration et posologie), Humains, Incidence, Lymphoedème (), Lymphoedème (diagnostic), Lymphoedème (épidémiologie), Pronostic, Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Stade de la tumeur, Tumeurs du sein (anatomopathologie), Tumeurs du sein (traitement médicamenteux), Épirubicine (administration et posologie), Études de suivi.
MESH :
- administration et posologie : Cyclophosphamide, Doxorubicine, Fluorouracil, Épirubicine.
- anatomopathologie : Bras, Tumeurs du sein.
- diagnostic : Lymphoedème.
- effets indésirables : Protocoles de polychimiothérapie antinéoplasique.
- traitement médicamenteux : Tumeurs du sein.
- épidémiologie : Australie, Douleur, Lymphoedème.
- Adulte d'âge moyen, Douleur, Femelle, Humains, Incidence, Lymphoedème, Pronostic, Stade de la tumeur, Études de suivi.
Wicri :
- geographic : Australie.

English descriptors

KwdEn :
- Antineoplastic Combined Chemotherapy Protocols (adverse effects), Arm (pathology), Australia (epidemiology), Breast Neoplasms (drug therapy), Breast Neoplasms (pathology), Cyclophosphamide (administration & dosage), Doxorubicin (administration & dosage), Epirubicin (administration & dosage), Female, Fluorouracil (administration & dosage), Follow-Up Studies, Humans, Incidence, Lymphedema (chemically induced), Lymphedema (diagnosis), Lymphedema (epidemiology), Middle Aged, Neoplasm Staging, Pain (chemically induced), Pain (epidemiology), Prognosis.
MESH :
- chemical , administration & dosage : Cyclophosphamide, Doxorubicin, Epirubicin, Fluorouracil.
- geographic , epidemiology : Australia.
- adverse effects : Antineoplastic Combined Chemotherapy Protocols.
- chemically induced : Lymphedema, Pain.
- diagnosis : Lymphedema.
- drug therapy : Breast Neoplasms.
- epidemiology : Lymphedema, Pain.
- pathology : Arm, Breast Neoplasms.
- Female, Follow-Up Studies, Humans, Incidence, Middle Aged, Neoplasm Staging, Prognosis.

Abstract

Taxanes can cause fluid accumulation by increasing extracellular fluid (ECF). Taxane-based regimens are standard of care for early breast cancer, but it is unknown whether they increase the risk of lymphedema. The aim of this study was to describe the incidence of lymphedema, generalized limb edema, and associated symptoms in women receiving adjuvant taxane-based chemotherapy.

DOI: 10.1089/lrb.2014.0030
PubMed: 25411764

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema following taxane-based chemotherapy in women with early breast cancer.</title>
<author><name sortKey="Lee, Mi Joung" sort="Lee, Mi Joung" uniqKey="Lee M" first="Mi-Joung" last="Lee">Mi-Joung Lee</name>
<affiliation wicri:level="3"><nlm:affiliation>1 Faculty of Health Sciences, University of Sydney , Sydney, Australia .</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>1 Faculty of Health Sciences, University of Sydney , Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beith, Jane" sort="Beith, Jane" uniqKey="Beith J" first="Jane" last="Beith">Jane Beith</name>
</author>
<author><name sortKey="Ward, Leigh" sort="Ward, Leigh" uniqKey="Ward L" first="Leigh" last="Ward">Leigh Ward</name>
</author>
<author><name sortKey="Kilbreath, Sharon" sort="Kilbreath, Sharon" uniqKey="Kilbreath S" first="Sharon" last="Kilbreath">Sharon Kilbreath</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25411764</idno>
<idno type="pmid">25411764</idno>
<idno type="doi">10.1089/lrb.2014.0030</idno>
<idno type="wicri:Area/PubMed/Corpus">001201</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001201</idno>
<idno type="wicri:Area/PubMed/Curation">001201</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001201</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001201</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001201</idno>
<idno type="wicri:Area/Ncbi/Merge">006D37</idno>
<idno type="wicri:Area/Ncbi/Curation">006D37</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">006D37</idno>
<idno type="wicri:Area/Main/Merge">002887</idno>
<idno type="wicri:Area/Main/Curation">002883</idno>
<idno type="wicri:Area/Main/Exploration">002883</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema following taxane-based chemotherapy in women with early breast cancer.</title>
<author><name sortKey="Lee, Mi Joung" sort="Lee, Mi Joung" uniqKey="Lee M" first="Mi-Joung" last="Lee">Mi-Joung Lee</name>
<affiliation wicri:level="3"><nlm:affiliation>1 Faculty of Health Sciences, University of Sydney , Sydney, Australia .</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>1 Faculty of Health Sciences, University of Sydney , Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beith, Jane" sort="Beith, Jane" uniqKey="Beith J" first="Jane" last="Beith">Jane Beith</name>
</author>
<author><name sortKey="Ward, Leigh" sort="Ward, Leigh" uniqKey="Ward L" first="Leigh" last="Ward">Leigh Ward</name>
</author>
<author><name sortKey="Kilbreath, Sharon" sort="Kilbreath, Sharon" uniqKey="Kilbreath S" first="Sharon" last="Kilbreath">Sharon Kilbreath</name>
</author>
</analytic>
<series><title level="j">Lymphatic research and biology</title>
<idno type="eISSN">1557-8585</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term>
<term>Arm (pathology)</term>
<term>Australia (epidemiology)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Cyclophosphamide (administration & dosage)</term>
<term>Doxorubicin (administration & dosage)</term>
<term>Epirubicin (administration & dosage)</term>
<term>Female</term>
<term>Fluorouracil (administration & dosage)</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Lymphedema (chemically induced)</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (epidemiology)</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Pain (chemically induced)</term>
<term>Pain (epidemiology)</term>
<term>Prognosis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Australie (épidémiologie)</term>
<term>Bras (anatomopathologie)</term>
<term>Cyclophosphamide (administration et posologie)</term>
<term>Douleur ()</term>
<term>Douleur (épidémiologie)</term>
<term>Doxorubicine (administration et posologie)</term>
<term>Femelle</term>
<term>Fluorouracil (administration et posologie)</term>
<term>Humains</term>
<term>Incidence</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Pronostic</term>
<term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term>
<term>Stade de la tumeur</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
<term>Épirubicine (administration et posologie)</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cyclophosphamide</term>
<term>Doxorubicin</term>
<term>Epirubicin</term>
<term>Fluorouracil</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Australia</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cyclophosphamide</term>
<term>Doxorubicine</term>
<term>Fluorouracil</term>
<term>Épirubicine</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Bras</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lymphedema</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arm</term>
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Australie</term>
<term>Douleur</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Douleur</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Lymphoedème</term>
<term>Pronostic</term>
<term>Stade de la tumeur</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Australie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Taxanes can cause fluid accumulation by increasing extracellular fluid (ECF). Taxane-based regimens are standard of care for early breast cancer, but it is unknown whether they increase the risk of lymphedema. The aim of this study was to describe the incidence of lymphedema, generalized limb edema, and associated symptoms in women receiving adjuvant taxane-based chemotherapy.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
<region><li>Nouvelle-Galles du Sud</li>
</region>
<settlement><li>Sydney</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Beith, Jane" sort="Beith, Jane" uniqKey="Beith J" first="Jane" last="Beith">Jane Beith</name>
<name sortKey="Kilbreath, Sharon" sort="Kilbreath, Sharon" uniqKey="Kilbreath S" first="Sharon" last="Kilbreath">Sharon Kilbreath</name>
<name sortKey="Ward, Leigh" sort="Ward, Leigh" uniqKey="Ward L" first="Leigh" last="Ward">Leigh Ward</name>
</noCountry>
<country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Lee, Mi Joung" sort="Lee, Mi Joung" uniqKey="Lee M" first="Mi-Joung" last="Lee">Mi-Joung Lee</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002883 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002883 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25411764
   |texte=   Lymphedema following taxane-based chemotherapy in women with early breast cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25411764" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Lymphedema following taxane-based chemotherapy in women with early breast cancer.

Lymphedema following taxane-based chemotherapy in women with early breast cancer.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.